Verge Medical Acquires RoVo™ System to Advance Peripheral Embolic Protection

CAMPBELL, Calif., June 30, 2025 /PRNewswire/ — Verge Medical, a privately held medical technology company focused on advancing physician-driven solutions to address persistent gaps in vascular care, today announced the acquisition of the RoVo™ System and its patented Temporary Occlusion Embolectomy (TOE) technology from 2MG Medical. The acquisition enhances Verge’s expanding portfolio of targeted, setting-specific solutions for coronary and peripheral vascular interventions.

Distal embolization is a serious complication that commonly occurs during atherectomy and other peripheral interventions. The RoVo System addresses risk of distal embolization with its novel TOE technique, which temporarily blocks downstream blood flow through compression while a vacuum-activated catheter is advanced and rotated to create a patented “vortex” effect that efficiently captures and removes debris.

“The RoVo System exemplifies Verge Medical’s mission to provide targeted solutions that are aligned with today’s clinical, workflow and reimbursement realities,” stated Mike Buck, CEO of Verge Medical. “RoVo is a smart, accessible technology designed to empower physicians to manage distal embolization with greater confidence. We look forward delivering innovative, practical tools like RoVo into the hands of physicians who need them most.”

The RoVo System joins the company’s expanding portfolio, which includes the FLASH™ Aorto-Ostial Angioplasty System, used in over 25,000 procedures to date, and the Wavella™ specialty infusion catheter for venous therapy.

With FDA clearance, the RoVo System and its patented TOE technique reinforce Verge Medical’s commitment to advancing vascular care through practical, physician-driven innovation designed to improve safety, efficiency, and outcomes.

About Verge Medical

Based in Campbell, California, Verge Medical is a private medical technology company advancing the future of vascular care through a platform of physician-led innovations. The company’s solutions are designed to address persistent gaps in coronary and peripheral interventions, improving procedural efficiency, safety, and patient outcomes. Learn more at www.vergemedical.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/verge-medical-acquires-rovo-system-to-advance-peripheral-embolic-protection-302493956.html

SOURCE Verge Medical